The discovery of RNA interference (RNAi) has been heralded as a major scientific breakthrough of the kind that happens only once every decade or so, and it represents one of the most promising and rapidly advancing frontiers in biology and drug discovery today.
With investigational RNAi therapeutics, it is possible to block the production of disease-causing proteins.
At Alnylam, groundbreaking discovery is leading to potential treatment options.